| |
| |
|
| Insider
Information: |
Eshelman Fredric N |
| Relationship: |
10% Owner |
| City: |
Wilmington |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
8,151,654 |
|
|
Indirect Shares
|
3,933,809 |
|
|
| Direct
Value |
$84,472,434 |
|
|
|
Indirect Value
|
$16,122,591 |
|
|
| Total
Shares |
12,085,463 |
|
|
| Total
Value |
$100,595,025 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
7
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
-7.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -45.7%
|
-43.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmaceutical Product Developme... |
PPDI |
Executive Chairman, Di... |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director, 10% Owner |
2014-07-02 |
0 |
2014-07-02 |
0 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2017-05-05 |
38,298 |
2016-03-11 |
0 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
Director, 10% Owner |
2017-11-13 |
250,000 |
2017-11-13 |
3,439,151 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2020-09-11 |
1,292,787 |
2020-09-11 |
319,085 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2020-11-25 |
6,570,569 |
2020-11-25 |
175,573 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-11-25 |
4 |
S |
$3.13 |
$54,349 |
D/D |
(17,364) |
6,570,569 |
0 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-11-24 |
4 |
S |
$3.15 |
$894,247 |
D/D |
(283,465) |
6,587,933 |
0 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-11-23 |
4 |
S |
$3.16 |
$421,347 |
D/D |
(133,346) |
6,871,398 |
0 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-11-19 |
4 |
D |
$3.35 |
$100,500 |
D/D |
(30,000) |
7,004,744 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,288 |
1,292,787 |
0 |
- |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-07-02 |
4 |
B |
$8.00 |
$15,000,000 |
D/D |
1,875,000 |
7,034,744 |
2.45 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-04-06 |
4 |
B |
$5.28 |
$233,715 |
I/I |
44,250 |
175,573 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-04-03 |
4 |
B |
$4.85 |
$169,740 |
I/I |
35,000 |
131,323 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-04-02 |
4 |
B |
$4.96 |
$35,792 |
I/I |
7,223 |
96,323 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-04-01 |
4 |
B |
$4.89 |
$220,122 |
I/I |
45,000 |
89,100 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-03-31 |
4 |
B |
$4.87 |
$146,112 |
I/I |
30,000 |
44,100 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-03-30 |
4 |
B |
$4.76 |
$67,106 |
I/I |
14,100 |
14,100 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2019-12-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,159,744 |
|
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2019-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,038 |
1,285,499 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • • |
2018-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
1,277,461 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • • |
2018-01-29 |
4 |
B |
$10.00 |
$3,350,000 |
D/D |
335,000 |
1,273,428 |
3.92 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Director |
– • • |
2017-11-13 |
4 |
B |
$19.73 |
$4,932,500 |
D/D |
250,000 |
250,000 |
3.92 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Director |
– • • |
2017-05-22 |
4 |
B |
$15.00 |
$4,500,000 |
I/I |
300,000 |
3,439,151 |
2.25 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Director |
– • • |
2017-05-22 |
4 |
A |
$0.00 |
$0 |
I/I |
3,139,151 |
3,139,151 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,406 |
38,298 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2017-05-03 |
4 |
D |
$9.66 |
$47,373 |
D/D |
(4,904) |
12,892 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2016-07-01 |
4 |
D |
$23.78 |
$618 |
D/D |
(26) |
17,796 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
16,726 |
17,822 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2016-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,096 |
1,096 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • • |
2014-07-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(174,495) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
